Drug Shortage Report for APO-DILTIAZ CD

Last updated on 2020-11-23 History
Report ID 121897
Drug Identification Number 02230997
Brand name APO-DILTIAZ CD
Common or Proper name DILTIAZ
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) DILTIAZEM HYDROCHLORIDE
Strength(s) 120MG
Dosage form(s) CAPSULE (CONTROLLED-DELIVERY) CAPSULE (CONTROLLED-DELIVERY)
Route of administration ORAL ORAL
Packaging size 500 BTL
ATC code C08DB
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-08-03
Estimated end date 2020-11-27
Actual end date 2020-11-20
Shortage status Resolved
Updated date 2020-11-23
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2020-11-23 French Compare
v6 2020-11-23 English Compare
v5 2020-10-30 French Compare
v4 2020-10-30 English Compare
v3 2020-08-06 French Compare
v2 2020-08-06 French Compare
v1 2020-08-06 English Compare

Showing 1 to 7 of 7